131 related articles for article (PubMed ID: 11933461)
1. [Role of the MIB-1 proliferative markers in the diagnosis and prognosis of tumors of the thyroid gland].
Ludvíková M; Ryska A; Hovorková E; Pikner R
Cesk Patol; 2002 Jan; 38(1):4-10. PubMed ID: 11933461
[TBL] [Abstract][Full Text] [Related]
2. Proliferative markers in diagnosis of thyroid tumors: a comparative study of MIB-1 and topoisomerase II-a immunostaining.
Ludvíková M; Holubec L; Ryska A; Topolcan O
Anticancer Res; 2005; 25(3A):1835-40. PubMed ID: 16033110
[TBL] [Abstract][Full Text] [Related]
3. MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland.
Rickert D; Mittermayer C; Lindenfelser R; Biesterfeld S
Anal Quant Cytol Histol; 2000 Jun; 22(3):229-34. PubMed ID: 10872040
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry].
Guyétant S; Michalak S; Valo I; Saint-André JP
Ann Pathol; 2003 Feb; 23(1):11-20. PubMed ID: 12743496
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis and proliferative activity in thyroid tumors.
Yoshida A; Nakamura Y; Imada T; Asaga T; Shimizu A; Harada M
Surg Today; 1999; 29(3):204-8. PubMed ID: 10192728
[TBL] [Abstract][Full Text] [Related]
6. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
7. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
8. [The use of immunohistochemistry in the differential diagnosis of thyroid gland tumors with follicular growth pattern].
Laco J; Ryska A
Cesk Patol; 2006 Jul; 42(3):120-4. PubMed ID: 16955558
[TBL] [Abstract][Full Text] [Related]
9. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
Tan A; Etit D; Bayol U; Altinel D; Tan S
Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
[TBL] [Abstract][Full Text] [Related]
10. The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors.
Vargas MP; Vargas HI; Kleiner DE; Merino MJ
Mod Pathol; 1997 Jan; 10(1):12-7. PubMed ID: 9021722
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of CD15, galectin-3 and HBME-1 expression in follicular thyroid neoplasms].
Bogdańska M; Górnicka B; Ziarkiewicz-Wróblewska B; Koperski L; Morton M; Wasiutyński A
Endokrynol Pol; 2006; 57(4):314-9. PubMed ID: 17006830
[TBL] [Abstract][Full Text] [Related]
12. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
[TBL] [Abstract][Full Text] [Related]
13. Proliferative activity of papillary carcinoma and benign papillary hyperplasia of thyroid follicular cells.
Dziecioł J; Lemancewicz D; Lebkowska U; Augustynowicz A; Dadan J; Klim B; Małdyk J
Folia Histochem Cytobiol; 2002; 40(2):201-2. PubMed ID: 12056645
[TBL] [Abstract][Full Text] [Related]
14. Role of Ki-67 as a proliferative marker in lesions of thyroid.
Pujani M; Arora B; Pujani M; Singh SK; Tejwani N
Indian J Cancer; 2010; 47(3):304-7. PubMed ID: 20587907
[TBL] [Abstract][Full Text] [Related]
15. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.
Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB
Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy.
Sofiadis A; Tani E; Foukakis T; Kjellman P; Skoog L; Höög A; Wallin G; Zedenius J; Larsson C
Int J Oncol; 2009 Aug; 35(2):369-74. PubMed ID: 19578751
[TBL] [Abstract][Full Text] [Related]
17. Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy.
Mehrotra P; Gonzalez MA; Johnson SJ; Coleman N; Wilson JA; Davies BR; Lennard TW
Laryngoscope; 2006 Aug; 116(8):1434-8. PubMed ID: 16885749
[TBL] [Abstract][Full Text] [Related]
18. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
Bernet VJ; Anderson J; Vaishnav Y; Solomon B; Adair CF; Saji M; Burman KD; Burch HB; Ringel MD
J Clin Endocrinol Metab; 2002 Oct; 87(10):4792-6. PubMed ID: 12364475
[TBL] [Abstract][Full Text] [Related]
19. Proliferative activity in thyroid tumors.
Yoshida A; Kamma H; Asaga T; Masuzawa C; Kawahara S; Mimura T; Ito K
Cancer; 1992 May; 69(10):2548-52. PubMed ID: 1568178
[TBL] [Abstract][Full Text] [Related]
20. The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors.
Sigstad E; Paus E; Bjøro T; Berner A; Grøholt KK; Jørgensen LH; Sobrinho-Simões M; Holm R; Warren DJ
Mod Pathol; 2012 Apr; 25(4):537-47. PubMed ID: 22157935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
